学术论文 | 研究方向 | 科研项目
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.,Int J Cancer,148(4):941-949
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.,Breast Cancer Res Treat,174 (3):639-647.
Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.,J Cancer Res Clin Oncol,145(5):1235-1242
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.,Int J Cancer,146(2):487-495
Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients.,Cancer Sci,110 (10):3368-3374
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negativebreast cancer patients.,Breast Cancer Res Treat,2020;179(3):605-614.
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers in a Large Cohort of Unselected Chinese Breast Cancer Patients.,Int J Cancer,2020;146(12):3335-3342.
BRCA1 c.5470_5477del, a Founder Mutation in Chinese Han Breast Cancer Patients.,Int J Cancer,2020;146(11):3044-3052
Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients.,Clin Cancer Res,2017,23(20):6113-6119
HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negativebreast cancer.,Oncol Lett ,2017;13(5):3793-3798
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.,Int J Cancer.,143(8):1935-1942
Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer.,Clin Genet,94(1):165-169.
Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.,JAMA Netw Open,4(4):e216259
Single-cell RNA sequencing reveals the cellular origin and evolution of breast cancer in BRCA1 mutation carriers.,Cancer Res,81(10):2600-2611
乳腺癌易感基因RECQL致瘤机制及潜在分子靶点的研究, 课题负责人 , 2020.1.1~2023.12.31, 国家自然科学基金委员会面上项目
科技北京百名领军人才培养工程, 课题负责人 , 2016.1.1~2018.12.31, 北京市科委 LJ201629
乳腺癌个体化治疗的临床与基础研究, 课题负责人 , 2014.1.1~2017.12.31, 科技部十二五支撑计划项目 2014BAI09B08
中国汉族乳腺癌BRCA1/2始祖突变的鉴定及功能研究, 课题负责人 , 2014.1.1~2017.12.31, 国家自然基金 81372832
DNA损伤修复蛋白在家族性乳腺癌早诊和辅助化疗中的应用, 子课题负责人 , 2013.3.13~2017.8.31, 科技部973项目/2013CB911004